ISDA

Entry Detail

PDB ID:

8WD4

Keywords:

ONCOPROTEIN

Title:

EGFR(L858R/T790/C797S) in complex with compound 5j

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Spodoptera frugiperda

PDB Version:

Deposition Date:

2023-09-14

Release Date:

2023-12-20

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.55 Å

R-Value Free:

0.22

R-Value Work:

0.19

R-Value Observed:

0.20

Space Group:

I 2 3

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Epidermal growth factor receptor
Mutations:L858R,T790M,C797S
Chain IDs:A
Chain Length:329
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P00533 Pfam ID:PF07714 EC:2.7.10.1

Ligand Molecules

W7W

Primary Citation

Synthesis, activity, and their relationships of 2,4-diaminonicotinamide derivatives as EGFR inhibitors targeting C797S mutation.

Kageji, H, Momose, T, Nagamoto, Y, Togashi, N, Yasumatsu, I, Nishikawa, Y, Kihara, K, Hiramoto, K, Minami, M, Kasanuki, N, Isoyama, T, Naito, H.Show

Bioorg.Med.Chem.Lett. 98 129575 129575 (2023)

PMID: 38065292 DOI: 10.1016/j.bmcl.2023.129575

Abstact

The C797S mutation is one of the major factors behind resistance to the third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors. Herein, we describe the discovery of the 2,4-diaminonicotinamide derivative 5j, which shows potent inhibitory activity against EGFR del19/T790M/C797S and L858R/T790M/C797S. We also report the structure-activity relationship of the 2,4-diaminonicotinamide derivatives and the co-crystal structure of 5j and EGFR del19/T790M/C797S.

Legend

Protein

Chemical

Disease

Primary Citation of related structures